{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:12:21Z","timestamp":1740373941255,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T00:00:00Z","timestamp":1279843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00210-010-0539-0","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T08:36:51Z","timestamp":1279787811000},"page":"201-212","source":"Crossref","is-referenced-by-count":5,"title":["The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant \u03b11\u03b22\u03b32s GABAA receptors expressed in HEK 293 cells"],"prefix":"10.1007","volume":"382","author":[{"given":"Josipa","family":"Vlaini\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja Jazvin\u0161\u0107ak","family":"Jembrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dubravka \u0160vob","family":"\u0160trac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danka","family":"Peri\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,23]]},"reference":[{"key":"539_CR1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1471-4159.2001.00664.x","volume":"79","author":"NJ Ali","year":"2001","unstructured":"Ali NJ, Olsen RW (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79:1100\u20131108","journal-title":"J Neurochem"},{"key":"539_CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00572441","volume":"330","author":"S Arbilla","year":"1985","unstructured":"Arbilla S, Depoortere H, George P, Langer SZ (1985) Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn Schmiedebergs Arch Pharmacol 330:248\u2013251","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"539_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2008.05.002","volume":"55","author":"J Auta","year":"2008","unstructured":"Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E (2008) Imidazenil: a low efficacy agonist at alpha1\u2014but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 55:148\u2013153","journal-title":"Neuropharmacology"},{"key":"539_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","volume":"62","author":"EA Barnard","year":"1998","unstructured":"Barnard EA, Skolnick P, Olsen RW, M\u00f6hler H, Sieghart W, Biggio G et al (1998) International Union of Pharmacology. XV. Subtypes of \u03b3-Aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 62:291\u2013313","journal-title":"Pharmacol Rev"},{"key":"539_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","volume":"8","author":"AN Bateson","year":"2002","unstructured":"Bateson AN (2002) Basic pharmacological mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8:5\u201321","journal-title":"Curr Pharm Des"},{"key":"539_CR6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1476-5381.1996.tb15512.x","volume":"118","author":"MJ Brown","year":"1996","unstructured":"Brown MJ, Bristow DR (1996) Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha1 subunit protein in rat cerebellar granule cells. Br J Pharmacol 118:1103\u20131110","journal-title":"Br J Pharmacol"},{"key":"539_CR7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1046\/j.1471-4159.1998.71031232.x","volume":"71","author":"MJ Brown","year":"1998","unstructured":"Brown MJ, Wood MD, Coldwell MC, Bristow DR (1998) \u03b3-Aminobutyric acidA receptor function is desensitized in rat cultured cerebellar granule cells following chronic flunitrazepam treatment. J Neurochem 71:1232\u20131240","journal-title":"J Neurochem"},{"key":"539_CR8","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1073\/pnas.94.16.8824","volume":"94","author":"A Buhr","year":"1997","unstructured":"Buhr A, Sigel E (1997) A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity. Proc Natl Acad Sci USA 94:8824\u20138829","journal-title":"Proc Natl Acad Sci USA"},{"key":"539_CR9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0021-9258(17)42291-5","volume":"269","author":"PA Calkin","year":"1994","unstructured":"Calkin PA, Barnes EM Jr (1994) \u03b3-Aminobutyric acid-A (GABAA) agonists down-regulate GABAA\/benzodiazepine receptor polypeptides from the surface of chick cortical neurons. J Biol Chem 269:1548\u20131553","journal-title":"J Biol Chem"},{"key":"539_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jmgm.2007.03.007","volume":"26","author":"SQ Ci","year":"2007","unstructured":"Ci SQ, Ren TR, Ma CX, Su ZG (2007) Modeling of alphak\/gamma2 (k\u2009=\u20091, 2, 3 and 5) interface of GABA A receptor and docking studies with zolpidem: implications for selectivity. J Mol Graph Model 26:537\u2013545","journal-title":"J Mol Graph Model"},{"key":"539_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2004.03.007","volume":"47","author":"DW Cope","year":"2004","unstructured":"Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, Halbsguth C, Hoeger H, Jolin HE, Jones A, McKenzie AN, Ogris W, Poeltl A, Sinkkonen ST, Vekovischeva OY, Korpi ER, Sieghart W, Sigel E, Somogyi P, Wisden W (2004) Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit. Neuropharmacology 47:17\u201334","journal-title":"Neuropharmacology"},{"key":"539_CR12","first-page":"1232","volume":"71","author":"E Costa","year":"1996","unstructured":"Costa E, Guidotti A (1996) Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 71:1232\u20131240","journal-title":"Trends Pharmacol Sci"},{"key":"539_CR13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0703717","volume":"131","author":"F Crestani","year":"2000","unstructured":"Crestani F, Martin JR, Mohler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251\u20131254","journal-title":"Br J Pharmacol"},{"key":"539_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(25)24899-6","volume":"237","author":"H Depoortere","year":"1986","unstructured":"Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237:649\u2013658","journal-title":"J Pharmacol Exp Ther"},{"key":"539_CR15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0026-895X(25)10544-0","volume":"48","author":"LL Devaud","year":"1995","unstructured":"Devaud LL, Smith FD, Grayson DR, Morrow AL (1995) Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase\u2013polymerase chain reaction analysis. Mol Pharmacol 48:861\u2013868","journal-title":"Mol Pharmacol"},{"key":"539_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2005.12.006","volume":"83","author":"JM Fahey","year":"2006","unstructured":"Fahey JM, Grassi JM, Reddi JM, Greenblatt DJ (2006) Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses. Pharmacol Biochem Behav 83:21\u201327","journal-title":"Pharmacol Biochem Behav"},{"key":"539_CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0169-328X(01)00164-4","volume":"92","author":"P Follesa","year":"2001","unstructured":"Follesa P, Cagetti E, Mancuso L, Biggio F, Manca A, Maciocco E, Massa F, Desole MS, Carta M, Busonero F, Sanna E, Biggio G (2001) Increase in expression of the GABAA receptor \u03b14 subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists. Mol Brain Res 92:138\u2013148","journal-title":"Mol Brain Res"},{"key":"539_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0028-3908(01)00167-8","volume":"42","author":"P Follesa","year":"2002","unstructured":"Follesa P, Mancuso L, Biggio F, Cagetti E, Franco M, Trapani G, Biggio G (2002) Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem. Neuropharmacology 42:191\u2013198","journal-title":"Neuropharmacology"},{"key":"539_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-8993(95)01226-5","volume":"707","author":"LK Friedman","year":"1996","unstructured":"Friedman LK, Gibbs TT, Farb DH (1996) gamma-aminobutyric acidA receptor regulation: heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture. Brain Res 707:100\u2013109","journal-title":"Brain Res"},{"key":"539_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/308074a0","volume":"308","author":"DW Gallager","year":"1984","unstructured":"Gallager DW, Lakoski JM, Gonsalves SF, Rauch SL (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308:74\u201377","journal-title":"Nature"},{"key":"539_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-1119(01)00701-6","volume":"278","author":"DM Gou","year":"2001","unstructured":"Gou DM, Chow LM, Chen NQ, Jiang DH, Li WX (2001) Construction and characterization of a cDNA library from 4-week-old human embryo. Gene 278:141\u2013147","journal-title":"Gene"},{"key":"539_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00168-4","volume":"329","author":"RA Holt","year":"1997","unstructured":"Holt RA, Bateson AN, Martin IL (1997a) Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol 329:129\u2013132","journal-title":"Eur J Pharmacol"},{"key":"539_CR23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0169-328X(97)00129-0","volume":"48","author":"RA Holt","year":"1997","unstructured":"Holt RA, Martin IL, Bateson AN (1997b) Chronic diazepam exposure decreases transcription of the rat GABA(A) receptor gamma2-subunit gene. Brain Res Mol Brain Res 48:164\u2013166","journal-title":"Brain Res Mol Brain Res"},{"key":"539_CR24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0026-895X(25)10146-6","volume":"45","author":"XJ Hu","year":"1994","unstructured":"Hu XJ, Ticku MK (1994) Chronic benzodiazepine agonist treatment reduces functional uncoupling of the recombinant of the \u03b3-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons. Mol Pharmacol 45:618\u2013625","journal-title":"Mol Pharmacol"},{"key":"539_CR25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0026-895X(25)09071-6","volume":"49","author":"F Impagnatiello","year":"1996","unstructured":"Impagnatiello F, Pesold C, Longone P, Caruncho H, Fritschy JM, Costa E, Guidotti A (1996) Modifications of \u03b3-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49:822\u2013831","journal-title":"Mol Pharmacol"},{"key":"539_CR26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neures.2008.03.005","volume":"61","author":"MJ Jembrek","year":"2008","unstructured":"Jembrek MJ, \u0160vob \u0160trac D, Vlaini\u0107 J, Peri\u010di\u0107 D (2008) The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res 61:234\u2013241","journal-title":"Neurosci Res"},{"key":"539_CR27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1046\/j.1471-4159.1994.62041643.x","volume":"62","author":"I Kang","year":"1994","unstructured":"Kang I, Lindquist DG, Kinane B, Ercolani L, Pritchard GA, Miller LG (1994) Isolation and characterization of the promoter of the human GABAA receptor \u03b11 subunit gene. J Neurochem 62:1643\u20131646","journal-title":"J Neurochem"},{"key":"539_CR28","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1046\/j.1471-4159.1994.63062349.x","volume":"63","author":"RL Klein","year":"1994","unstructured":"Klein RL, Whiting PJ, Harris RA (1994) Benzodiazepine treatment causes uncoupling of recombinant GABAA receptors expressed in stably transfected cells. J Neurochem 63:2349\u20132352","journal-title":"J Neurochem"},{"key":"539_CR29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0022-3565(25)10707-6","volume":"274","author":"RL Klein","year":"1995","unstructured":"Klein RL, Mascia MP, Harkness PC, Hadingham KL, Whiting PJ, Harris RA (1995) Regulation of allosteric coupling and function of stably expressed \u03b3-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists. J Pharmacol Exp Ther 274:1484\u20131492","journal-title":"J Pharmacol Exp Ther"},{"key":"539_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","volume":"67","author":"ER Korpi","year":"2002","unstructured":"Korpi ER, Grunder G, L\u00fcddens H (2002) Drug interactions at GABA(A) receptors. Prog Neurobiol 67:113\u2013159","journal-title":"Prog Neurobiol"},{"key":"539_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"539_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","volume":"19","author":"RM McKernan","year":"1996","unstructured":"McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139\u2013143","journal-title":"Trends Neurosci"},{"key":"539_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Pharmacol Rev 60:243\u2013260","journal-title":"Pharmacol Rev"},{"key":"539_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.lfs.2004.07.013","volume":"76","author":"D Peri\u010di\u0107","year":"2004","unstructured":"Peri\u010di\u0107 D, Lazi\u0107 J, Jembrek MJ, \u0160trac DS, Raj\u010dan I (2004) Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances the maximum number of benzodiazepine binding sites. Life Sci 76:303\u2013317","journal-title":"Life Sci"},{"key":"539_CR35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00210-007-0152-z","volume":"375","author":"D Peri\u010di\u0107","year":"2007","unstructured":"Peri\u010di\u0107 D, \u0160trac DS, Jembrek MJ, Vlaini\u0107 J (2007) Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with \u03b11\u03b22\u03b32s subunits of GABA(A) receptors. Naunyn Schmiedebergs Arch Pharmacol 375:177\u2013187","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"539_CR36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-008-0020-0","volume":"115","author":"D Peri\u010di\u0107","year":"2008","unstructured":"Peri\u010di\u0107 D, Vlaini\u0107 J, \u0160trac DS (2008) Sedative and anticonvulsant effects of zolpidem in adult and aged mice. J Neural Transm 115:795\u2013802","journal-title":"J Neural Transm"},{"key":"539_CR37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(90)90375-G","volume":"87","author":"G Perrault","year":"1990","unstructured":"Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 87:487\u2013494","journal-title":"Eur J Pharmacol"},{"key":"539_CR38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)10339-X","volume":"263","author":"G Perrault","year":"1992","unstructured":"Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298\u2013303","journal-title":"J Pharmacol Exp Ther"},{"key":"539_CR39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3565(25)12410-5","volume":"276","author":"RJ Primus","year":"1996","unstructured":"Primus RJ, Yu J, Xu J, Hartnett C, Meyyappan M, Kostas C, Ramabhadran TV, Gallager DW (1996) Allosteric uncoupling after chronic benzodiazepine exposure of recombinant \u03b3-aminobutyric acidA receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. J Pharmacol Exp Ther 276:882\u2013890","journal-title":"J Pharmacol Exp Ther"},{"key":"539_CR40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","volume":"338","author":"DB Pritchett","year":"1989","unstructured":"Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, Seeburg PH (1989) Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338:582\u2013585","journal-title":"Nature"},{"key":"539_CR41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0026-895X(25)10901-2","volume":"37","author":"DJ Roca","year":"1990","unstructured":"Roca DJ, Schiller GD, Friedman L, Rozenberg I, Gibbs TT, Farb DH (1990) \u03b3-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines. Mol Pharmacol 37:710\u2013719","journal-title":"Mol Pharmacol"},{"key":"539_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","volume":"18","author":"DJ Sanger","year":"2004","unstructured":"Sanger DJ (2004) The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18:9\u201315","journal-title":"CNS Drugs"},{"key":"539_CR43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)02191-X","volume":"451","author":"E Sanna","year":"2002","unstructured":"Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Biggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 451:103\u2013110","journal-title":"Eur J Pharmacol"},{"key":"539_CR44","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.01-0995fje","volume":"16","author":"G Shaw","year":"2002","unstructured":"Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869-871","journal-title":"FASEB J"},{"key":"539_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2008.09.093","volume":"1246","author":"D \u0160vob \u0160trac","year":"2008","unstructured":"\u0160vob \u0160trac D, Vlaini\u0107 J, Jazvin\u0161\u0107ak Jembrek M, Peri\u010di\u0107 D (2008) Differential effects of diazepam treatment and withdrawal on recombinant GABAA receptor expression and functional coupling. Brain Res 1246:29\u201340","journal-title":"Brain Res"},{"key":"539_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/pr.109.002063","volume":"62","author":"M Uusi-Oukari","year":"2010","unstructured":"Uusi-Oukari M, Korpi ER (2010) Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev 62:97\u2013135","journal-title":"Pharmacol Rev"},{"key":"539_CR47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/mcne.2000.0856","volume":"16","author":"M Uusi-Oukari","year":"2000","unstructured":"Uusi-Oukari M, Heikkil\u00e4 J, Sinkkonen ST, M\u00e4kel\u00e4 R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster. Mol Cell Neurosci 16:34\u201341","journal-title":"Mol Cell Neurosci"},{"key":"539_CR48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2125.2007.02861.x","volume":"64","author":"C Victorri-Vigneau","year":"2007","unstructured":"Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198\u2013209","journal-title":"Br J Clin Pharmacol"},{"key":"539_CR49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.neuropharm.2009.03.010","volume":"56","author":"J Vlaini\u0107","year":"2009","unstructured":"Vlaini\u0107 J, Peri\u010di\u0107 D (2009) Effect of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 56:1124\u20131130","journal-title":"Neuropharmacology"},{"key":"539_CR50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainres.2009.11.018","volume":"1310","author":"J Vlaini\u0107","year":"2010","unstructured":"Vlaini\u0107 J, Peri\u010di\u0107 D (2010) Zolpidem is a potent anticonvulsant in adult and aged mice. Brain Res 1310:181\u2013188","journal-title":"Brain Res"},{"key":"539_CR51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","volume":"5","author":"KA Wafford","year":"2005","unstructured":"Wafford KA (2005) GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol 5:47\u201352","journal-title":"Curr Opin Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0539-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-010-0539-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0539-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:19:50Z","timestamp":1740291590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-010-0539-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,23]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s00210-010-0539-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2010,7,23]]}}}